Valsartan And Hydrochlorothiazide
Product Images NDC 53002-1785

4 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 53002-1785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 01)

Image 1 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 01)
A set of four line graphs depicting the probability of achieving specific systolic and diastolic blood pressure targets at Week 8 with Valsartan and Hydrochlorothiazide treatment. The charts compare results for blood pressure thresholds of less than 140 mmHg, 130 mmHg systolic, and less than 90 mmHg, 80 mmHg diastolic, across baseline SBP and DBP values. Different line markers represent various treatment groups, including Valsartan and Hydrochlorothiazide combinations, Valsartan alone, Hydrochlorothiazide alone, and placebo.*
FDA Label Image

Image 2 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 02)

Image 2 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 02)
Chemical structure of the active ingredient Valsartan showing its molecular configuration including functional groups and stereochemistry as depicted in the image.*
FDA Label Image

Image-3 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 03)

Image-3 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 03)
Chemical structure of the active ingredient, representing a sulfonamide compound with chlorine and sulfonamide groups on an aromatic ring.*
FDA Label Image

Label Image (Lbl530021785)

Label Image (Lbl530021785)
Packaging label for Valsartan and Hydrochlorothiazide 160-25 mg tablets by RPK Pharmaceuticals, Inc. The label indicates 90 tablets per container, with instructions to take one tablet daily as directed. It includes sections for patient and prescription information, barcodes, and billing codes. The label also shows storage conditions and lot numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.